For the mechanism, ALKBH5 enhances the expression of AXL by preventing the YTHDF2-medaited mRNA decay, and AXL is a receptor tyrosine kinase (RTK) phosphorylating FLT3 to accelerate development of AML [111, 135]. This evidence concerns the gene ALKBH5 and acute myeloid leukemia.